Nitrosative stress-induced Parkinsonian Lewy-like aggregates prevented through polyphenolic phytochemical analog intervention

Biochemical and Biophysical Research Communications

Volumn 404, Issue 1, 2011, Pages 324-329

  Pal, Rituraj ^a   Miranda, Manuel ^a   Narayan, Mahesh ^a  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

Author keywords

EF 24; Lewy body; Neurodegenerative disorders; Nitrosative stress; Protein disulfide isomerase; Synphilin 1

Indexed keywords

3,5 BIS(2 FLUROBENZYLIDENE) PIPERIDIN 4 ONE; CURCUMIN; EF 24; GREEN FLUORESCENT PROTEIN; NEUROPROTECTIVE AGENT; NORDIHYDROGUAIARETIC ACID; POLYPHENOL DERIVATIVE; PROTEIN DISULFIDE ISOMERASE; ROTENONE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROBLASTOMA CELL; NEUROPROTECTION; NITROSATIVE STRESS; OXIDATION REDUCTION REACTION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BENZYLIDENE COMPOUNDS; CARRIER PROTEINS; CELL LINE, TUMOR; CURCUMIN; FLAVONOIDS; FREE RADICAL SCAVENGERS; GREEN FLUORESCENT PROTEINS; HUMANS; LEWY BODIES; NERVE TISSUE PROTEINS; NITRIC OXIDE; PARKINSON DISEASE; PHENOLS; PIPERIDONES; REACTIVE OXYGEN SPECIES; STRESS, PHYSIOLOGICAL;

PARKINSONIA;

EID: 78650881856     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.11.117     Document Type: Article

References (38)

1. Hindle J.V. Ageing neurodegeneration and Parkinson's disease. Age Ageing 2010, 39:156-161.
2. Schiesling C., Kieper N., Seidel K., Kruger R. Review: familial Parkinson's disease - genetics clinical phenotype and neuropathology in relation to the common sporadic form of the disease. Neuropathol. Appl. Neurobiol. 2008, 34:255-271.
3. Su B., Liu H., Wang X., Chen S.G., Siedlak S.L., Kondo E., Choi R., Takeda A., Castellani R.J., Perry G., Smith M.A., Zhu X., Lee H.G. Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease. Mol. Neurodegener. 2009, 4:32.
4. Olanow C.W. The pathogenesis of cell death in Parkinson's disease - 2007. Mov. Disord. 2007, 22(Suppl 17):S335-342.
5. Mattson M.P. Nitro-PDI incites toxic waste accumulation. Nat. Neurosci. 2006, 9:865-867.
6. Walsh D.M., Selkoe D.J. Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept. Lett. 2004, 11:213-228.
7. Uehara T., Nakamura T., Yao D., Shi Z.Q., Gu Z., Ma Y., Masliah E., Nomura Y., Lipton S.A. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 2006, 441:513-517.
8. Uehara T. Accumulation of misfolded protein through nitrosative stress linked to neurodegenerative disorders. Antioxid. Redox Signal. 2007, 9:597-601.
9. Wakabayashi K., Tanji K., Mori F., Takahashi H. The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology 2007, 27:494-506.
10. Uversky V.N. Alpha-synuclein misfolding and neurodegenerative diseases. Curr. Protein Pept. Sci. 2008, 9:507-540.
11. Tan J.M., Wong E.S., Lim K.L. Protein misfolding and aggregation in Parkinson's disease. Antioxid. Redox Signal. 2009, 11:2119-2134.
12. Gispert-Sanchez S., Auburger G. The role of protein aggregates in neuronal pathology: guilty, innocent, or just trying to help?. J. Neural. Transm. Suppl. 2006, 111-117.
13. Gu Z., Nakamura T., Lipton S.A. Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Mol. Neurobiol. 2010, 41:55-72.
14. Knott A.B., Bossy-Wetzel E. Nitric oxide in health and disease of the nervous system. Antioxid. Redox Signal. 2009, 11:541-554.
15. Nakamura T., Lipton S.A. Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases. Antioxid. Redox Signal. 2008, 10:87-101.
16. Benhar M., Forrester M.T., Stamler J.S. Nitrosative stress in the ER: a new role for S-nitrosylation in neurodegenerative diseases. ACS Chem. Biol. 2006, 1:355-358.
17. Chung K.K. Say NO to neurodegeneration: role of S-nitrosylation in neurodegenerative disorders. Neurosignals 2006, 15:307-313.
18. Tsang A.H., Chung K.K. Oxidative and nitrosative stress in Parkinson's disease. Biochim. Biophys. Acta 2009, 1792:643-650.
19. Foster M.W., Hess D.T., Stamler J.S. Protein S-nitrosylation in health and disease: a current perspective. Trends Mol. Med. 2009, 15:391-404.
20. Pal R., Cristan E.A., Schnittker K., Narayan M. Rescue of ER oxidoreductase function through polyphenolic phytochemical intervention: implications for subcellular traffic and neurodegenerative disorders. Biochem. Biophys. Res. Commun. 2010, 392:567-571.
21. Chen Q. Nordihydroguaiaretic acid analogues: their chemical synthesis and biological activities. Curr. Top. Med. Chem. 2009, 9:1636-1659.
22. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 2007, 4:807-818.
23. Chauhan D.P. Chemotherapeutic potential of curcumin for colorectal cancer. Curr. Pharm. Des. 2002, 8:1695-1706.
24. Arteaga S., Andrade-Cetto A., Cardenas R. Larrea tridentata (Creosote bush) an abundant plant of Mexican and US-American deserts and its metabolite nordihydroguaiaretic acid. J. Ethnopharmacol. 2005, 98:231-239.
25. Bright J.J. Curcumin and autoimmune disease. Adv. Exp. Med. Biol. 2007, 595:425-451.
26. Goel A., Kunnumakkara A.B., Aggarwal B.B. Curcumin as " Curecumin": from kitchen to clinic. Biochem. Pharmacol. 2008, 75:787-809.
27. Adams B.K., Ferstl E.M., Davis M.C., Herold M., Kurtkaya S., Camalier R.F., Hollingshead M.G., Kaur G., Sausville E.A., Rickles F.R., Snyder J.P., Liotta D.C., Shoji M. Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents. Bioorg. Med. Chem. 2004, 12:3871-3883.
28. Woycechowsky K.J., Raines R.T. Native disulfide bond formation in proteins. Curr. Opin. Chem. Biol. 2000, 4:533-539.
29. Tu B.P., Weissman J.S. Oxidative protein folding in eukaryotes: mechanisms and consequences. J. Cell. Biol. 2004, 164:341-346.
30. Narayan M., Welker E., Wedemeyer W.J., Scheraga H.A. Oxidative folding of proteins. Acc. Chem. Res. 2000, 33:805-812.
31. Arolas J.L., Aviles F.X., Chang J.Y., Ventura S. Folding of small disulfide-rich proteins: clarifying the puzzle. Trends Biochem. Sci. 2006, 31:292-301.
32. Wilkinson B., Gilbert H.F. Protein disulfide isomerase. Biochim. Biophys. Acta 2004, 1699:35-44.
33. Tian G., Xiang S., Noiva R., Lennarz W.J., Schindelin H. The crystal structure of yeast protein disulfide isomerase suggests cooperativity between its active sites. Cell 2006, 124:61-73.
34. Hawkins H.C., Freedman R.B. The reactivities and ionization properties of the active-site dithiol groups of mammalian protein disulphide-isomerase. Biochem. J. 1991, 275(Pt 2):335-339.
35. Weissman J.S., Kim P.S. Efficient catalysis of disulphide bond rearrangements by protein disulphide isomerase. Nature 1993, 365:185-188.
36. Gilbert H.F. Protein disulfide isomerase. Methods Enzymol. 1998, 290:26-50.
37. Romisch K. A cure for traffic jams: small molecule chaperones in the endoplasmic reticulum. Traffic 2004, 5:815-820.
38. Romisch K. Endoplasmic reticulum-associated degradation. Annu. Rev. Cell. Dev. Biol. 2005, 21:435-456.